Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients.
Martin SalzmannKarolina BenesovaKristina Buder-BakhayaDimitrios PapamichailAntonia Dimitrakopoulou-StraussHanns-Martin LorenzAlexander H EnkJessica C HasselPublished in: Cancers (2020)
Arthralgia is a common side effect in patients receiving BRAFi +/- MEKi therapy and often presents a clinical pattern similar to that observed in RA patients. Its occurrence was associated with longer-lasting tumor control.